Pharma Contract Manufacturing: Risk Management, Quality, Tech Transfer & Business Continuity
Now more than ever, pharmaceutical and biotech companies are using Contract Manufacturing Organizations (CMOs) to help them with scalability and focusing on drug discovery and drug marketing. CMOs are a response to the competitive international nature of the pharmaceutical market as well as the increasing demand for outsourced services.
IQPC’s Pharma Contact Manufacturing event (geared for big pharma and small to mid size biotechs) will focus on technical rather than relationship building topics.
Senior Director, Biotherapeutics and Vaccines Outsourcing,
Director of CMC and Quality
Sr. Supply Chain Specialist
Heron Therapeutics, Inc.
SVP Technical Operations
Head of Supply Chain Americas
Supply Chain Project Manager
Workgroup Member HDA, GS1 DSCSA
Head of External Manufacturing, Latin America
Partner, Life Sciences and Healthcare
Director of CMC
Healthcare Futurist, SVP, Quality
What to expect in 2019
Interactive Discussion Groups broken down by big pharma focus and small pharma focus
An interactive workshop on preparing now for 2023 interoperability
An exhibition hall featuring CMOs and solution providers
Thought provoking session on risk management and tech transfer strategies for expanding patient access
A unique approach to vendor selection that focuses on what you can live with versus what’s a deal breaker
Practical case studies showcasing technical and technological innovation in CMO capabilities